Chemycal has been acquired by 3E

Learn More

Consultations following requests from ECHA's Executive Director to the Committees | 21 October 2020


Your substances

None

This news contains references also to other Substances




2,2'-dichloro-4,4'-methylenedianiline (MOCA)202-918-9101-14-4Request to assess the further information submitted by applicants for twelve applications for authorization and integration into the relevant opinionsREACHLaw Ltd in its legal capacity as Only Representative of Suzhou Xiangyuan Special Fine Chemical Co., LtdCommittee for Socio-economic Analysis (SEAC)21/10/202011/18/2020
Chromium trioxide215-607-81333-82-0Request to assess the further information submitted by applicants for twelve applications for authorization and integration into the relevant opinionsREACHLaw Ltd as Only Representative on behalf of Joint Stock Company “Novotroitsk Plant of Chromium Compounds”Committee for Socio-economic Analysis (SEAC)21/10/202011/18/2020
Chromium trioxide215-607-81333-82-0Request to assess the further information submitted by applicants for twelve applications for authorization and integration into the relevant opinionsHAPOC GmbH & Co KGCommittee for Socio-economic Analysis (SEAC)21/10/202011/18/2020
Chromium trioxide215-607-81333-82-0Request to assess the further information submitted by applicants for twelve applications for authorization and integration into the relevant opinionsChemservice GmbH in its legal capacity as Only Representative of Brother CISA (Pty) Ltd .;
Atotech Deutschland GmbH
Boeing Distribution, Inc .;
Prospere Chemical Logistic OÜ as Only Representative of Aktyubinsk Chromium Chemicals Plant, Kazakhstan
CROMITAL SPA in its legal capacity as Only Representative of Soda Sanayii AS
Elementis Chromium LLP in its legal capacity as Only Representative of Elementis Chromium Inc.
MacDermid Enthone GmbH
Committee for Socio-economic Analysis (SEAC)21/10/202011/18/2020

Link to the Consultations following requests from ECHA's Executive Director to the Committees

                   

Related News

Loading...